Grant: Banting Postdoctoral Fellowship Program
McMaster University
$140,000.00
Macrophage AMP-activated protein kinase (AMPK): its role in regulating obesity induced-inflammation, insulin resistance and atherosclerosis
EF 2010-11
Résumé
Canadian society is experiencing an epidemic of obesity (particularly during childhood), and heart disease and stroke are the leading cause of death and morbidity. Obesity, brought on by diets rich in calorie dense foods and inactivity, can cause insulin resistance and atherosclerosis (plaque build up in the arteries), which overtime leads to type 2 diabetes and cardiovascular disease (CVD), respectively. But all is not lost! At the cellular front line in the fight against these disorders are macrophages. These specialized cells play a critical role in our immune system by sensing foreign invaders and mounting an attack. Recent evidence shows that in obesity, the macrophages that are meant to protect us are reprogrammed and contribute to a state of 'chronic inflammation,' which then leads to insulin resistance and atherosclerosis. Exciting new findings from our lab have shown that mice lacking a protein called AMP-activated protein kinase (AMPK) specifically in their macrophages have increased inflammation and insulin resistance. AMPK is a master regulator of metabolism that can turn on fat burning and increase energy in the cell by making more mitochondria (the power house of the cell). The objective of this proposal is to determine the specific mechanisms by which AMPK regulates this inflammatory switch in macrophages during obesity and if this plays a role in CVD. We will test the hypothesis that players in fat metabolism, which can be regulated by AMPK, direct the macrophages to an inflammatory state and lead to insulin resistance. We further hypothesize that AMPK can directly control cholesterol balance in the macrophage. Given the Supervisor's expertise in obesity, inflammation and insulin action, the infrastructure and resources available at McMaster and the Candidate's expertise in molecular and lipid metabolism, our goal is to shed light on the connection between inflammation and lipid metabolism and identify new ways to prevent type 2 diabetes and CVD
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
218903
Name
Fullerton Morgan D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Macrophage AMP-activated protein kinase (AMPK): its role in regulating obesity induced-inflammation, insulin resistance and atherosclerosis
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Amp-Activated Protein Kinase (Ampk); Atherosclerosis; Bone Marrow Transplant Chimeras; Cholesterol; Fatty Acid Metabolism; Hyperinsulinemic-Euglycemic Clamp; Inflammation; Macrophage Polarization; Mitochondrial Biogensis; Type 2 Diabetes
Abstract
Canadian society is experiencing an epidemic of obesity (particularly during childhood), and heart disease and stroke are the leading cause of death and morbidity. Obesity, brought on by diets rich in calorie dense foods and inactivity, can cause insulin resistance and atherosclerosis (plaque build up in the arteries), which overtime leads to type 2 diabetes and cardiovascular disease (CVD), respectively. But all is not lost! At the cellular front line in the fight against these disorders are macrophages. These specialized cells play a critical role in our immune system by sensing foreign invaders and mounting an attack. Recent evidence shows that in obesity, the macrophages that are meant to protect us are reprogrammed and contribute to a state of 'chronic inflammation,' which then leads to insulin resistance and atherosclerosis. Exciting new findings from our lab have shown that mice lacking a protein called AMP-activated protein kinase (AMPK) specifically in their macrophages have increased inflammation and insulin resistance. AMPK is a master regulator of metabolism that can turn on fat burning and increase energy in the cell by making more mitochondria (the power house of the cell). The objective of this proposal is to determine the specific mechanisms by which AMPK regulates this inflammatory switch in macrophages during obesity and if this plays a role in CVD. We will test the hypothesis that players in fat metabolism, which can be regulated by AMPK, direct the macrophages to an inflammatory state and lead to insulin resistance. We further hypothesize that AMPK can directly control cholesterol balance in the macrophage. Given the Supervisor's expertise in obesity, inflammation and insulin action, the infrastructure and resources available at McMaster and the Candidate's expertise in molecular and lipid metabolism, our goal is to shed light on the connection between inflammation and lipid metabolism and identify new ways to prevent type 2 diabetes and CVD
Competitiondate
201011
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Fullerton, Morgan D
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~